Tang Donald F

SEC source: 0001213900-25-081179 · ownership.xml · nonDerivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,425

F1 · price: This figure is the weighted average sales price of multiple trades ranging from $6.64 to $7.15 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-25-079492 · ownership.xml · nonDerivative · entry 2

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,178

SEC source: 0001213900-25-079492 · ownership.xml · nonDerivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,237

SEC source: 0001213900-25-074543 · ownership.xml · derivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,335

Underlying: Class A Common Stock · 5,335 shares

Expires 2035-06-26

F1 · derivative.exercise_date: All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date.

SEC source: 0000950170-25-091150 · ownership.xml · derivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,950

Underlying: Common Stock · 21,950 shares

Expires 2035-06-24

F1 · derivative.exercise_date: 100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001854270-25-000030 · wk-form4_1741724435.xml · derivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,900

Underlying: Common Stock · 43,900 shares

Expires 2035-03-06

F1 · derivative.exercise_date: 100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001854270-24-000125 · wk-form4_1733865539.xml · derivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2034-12-08

F1 · derivative.exercise_date: The shares underlying this option vest in 36 substantially equal monthly installments over three years from December 9, 2024, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001213900-24-051734 · ownership.xml · nonDerivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,360,129

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-23-046252 · ownership.xml · nonDerivative · entry 2

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,261,168

F2 · kind: Distribution received from a fund in which the Reporting Person is an investor.

SEC source: 0001213900-23-046252 · ownership.xml · nonDerivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,161,168

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-039403 · ownership.xml · nonDerivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,095,194

F1 · kind: D8 Sponsor LLC distributed these shares to its members, including the Reporting Person, on a pro rata basis, for no consideration.

SEC source: 0001213900-22-031148 · ownership.xml · nonDerivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,740

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-21-062144 · ownership.xml · nonDerivative · entry 2

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,624

F2 · price: Consists of RSUs. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Tang's continued service through the applicable vesting date.

SEC source: 0001213900-21-062144 · ownership.xml · nonDerivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,085

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Tang's continued service through the applicable vesting date.

SEC source: 0001213900-21-049215 · ownership.xml · derivative · entry 2

D8 Sponsor LLC · CIK 0001813880 · Director · 10% owner · Director by Deputization

CHU DAVID · CIK 0001199554 · Director

Tang Donald F · CIK 0001817370 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A ordinary shares · 8,535,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

F1 · kind: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

F1 · derivative.exercise_date: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

F1 · derivative.expiration_date: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

SEC source: 0001213900-21-049215 · ownership.xml · nonDerivative · entry 1

D8 Sponsor LLC · CIK 0001813880 · Director · 10% owner · Director by Deputization

CHU DAVID · CIK 0001199554 · Director

Tang Donald F · CIK 0001817370 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,535,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

F1 · price: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

F2 · balance_after: D8 Sponsor LLC is the record holder of the securities reported herein. David Chu and Donald Tang are the managers of D8 Sponsor LLC and share voting and investment discretion with respect to the shares of Class A common stock held of record by D8 Sponsor LLC. Each of the Messrs. Chu and Tang disclaims any beneficial ownership of the securities held by D8 Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly.